Role of CD95-Mediated Adipocyte Loss in Autoimmune Lipodystrophy | Zendy

Pamela FischerPosovszky | Zendy; Helge Hebestreit | Zendy; Albert K. Hofmann | Zendy; Gudrun Strauß | Zendy; Peter Möller | Zendy; KlausMichael Debatin | Zendy; Martin Wabitsch | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Role of CD95-Mediated Adipocyte Loss in Autoimmune Lipodystrophy

Author(s) -

Pamela FischerPosovszky,

Helge Hebestreit,

Albert K. Hofmann,

Gudrun Strauß,

Peter Möller,

KlausMichael Debatin,

Martin Wabitsch

Publication year - 2006

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2005-0737

Subject(s) - adipose tissue , lipodystrophy , adipocyte , medicine , endocrinology , adiponectin , inflammation , biology , insulin resistance , immunology , insulin , human immunodeficiency virus (hiv) , viral load , antiretroviral therapy

Lipodystrophies are rare disorders characterized by the selective loss of adipose tissue. Metabolic complications increase in severity with the extent of fat loss. In some forms of acquired lipodystrophy, the loss of fat is suggested to be a result of autoimmune destruction of adipocytes. Here, the pathogenic mechanism is still poorly understood.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research